You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 100 No. 2, AUGUST 1957 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (27)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Plasma Thromboplastin Antecedent (PTA) Deficiency

EDMUND W. CAMPBELL, M.D.; IRMA B. MEDNICOFF; WILLIAM DAMESHEK, M.D.

AMA Arch Intern Med. 1957;100(2):232-240.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Plasma thromboplastin antecedent (PTA) deficiency was first described by R. L. Rosenthal et al., in 1953,1 as a mild to moderately severe hereditary hemorrhagic disease resembling hemophilia but occurring in both males and females. Further studies by the same group revealed fairly well-defined distinctions between antihemophilic globulin (AHG), plasma thromboplastin component (PTC), and PTA.2 Only a few subsequent cases of PTA deficiency have been reported.3,4 The present report deals with a family in which a coagulation disorder, eventually diagnosed as PTA deficiency, was found.* Both males and females were affected, inheritance taking place either through males or females. Of the 10 members of the family available for study, 5 showed indications of the disease (Fig. 1). However, the variability in laboratory tests indicated a somewhat less well-defined character of the deficient factor than is found in either the AHG or the PTC coagulation defect. In the case . . . [Full Text PDF of this Article]


Author Affiliations

Boston

From the Blood Research Laboratory, a unit of the Ziskind Laboratories, New England Center Hospital, and the Department of Medicine, Tufts University Medical School.


Footnotes

Submitted for publication Feb. 21, 1957.

This work was supported by U. S. P. H. S. National Heart Institute Grant No. H-2636.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1957 American Medical Association. All Rights Reserved.